-
1
المؤلفون: Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
المساهمون: Center for Liver, Digestive and Metabolic Diseases (CLDM)
المصدر: Pediatrics, 151(1):e2022058037. AMER ACAD PEDIATRICS
مصطلحات موضوعية: Adult, Diarrhea, Adolescent, Inflammatory Bowel Diseases/diagnosis, Inflammatory Bowel Diseases, Colitis, Crohn Disease/complications, Colitis, Ulcerative/diagnosis, Abdominal Pain, Abdominal Pain/etiology, Crohn Disease, Pediatrics, Perinatology and Child Health, Humans, Colitis, Ulcerative, Ulcerative/diagnosis, Child
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd50e2ce5ac05b86ebf7b8bc8e5a8199
https://doi.org/10.1542/peds.2022-058037 -
2
المؤلفون: Marleen Bouhuys, Willem S. Lexmond, Patrick F. van Rheenen
المصدر: Biomedicines. 10(5)
مصطلحات موضوعية: ETANERCEPT 25 MG, tumor necrosis factor inhibitors, Medicine (miscellaneous), ANKYLOSING-SPONDYLITIS, TARGET RECOMMENDATIONS, FACTOR INHIBITORS, General Biochemistry, Genetics and Molecular Biology, LOW DISEASE-ACTIVITY, RHEUMATOID-ARTHRITIS, certolizumab pegol, ANTI-TNF AGENTS, CLINICAL REMISSION, dose reduction, interval lengthening, adalimumab, PSORIATIC-ARTHRITIS, adverse effects, golimumab, infliximab, etanercept
-
3
المؤلفون: Marleen Bouhuys, Willem S. Lexmond, Edouard Louis, Triana Lobatón, Patrick F. van Rheenen, Henk Groen, Stephanie Van Biervliet, Gerard Dijkstra, Jordi Guardiola
المساهمون: Groningen Institute for Organ Transplantation (GIOT), Groningen Institute for Gastro Intestinal Genetics and Immunology (3GI), Translational Immunology Groningen (TRIGR), Value, Affordability and Sustainability (VALUE), Reproductive Origins of Adult Health and Disease (ROAHD), Center for Liver, Digestive and Metabolic Diseases (CLDM)
المصدر: BMJ OPEN
BMJ Open, Vol 11, Iss 11 (2021)
BMJ Open
Dipòsit Digital de la UB
Universidad de Barcelona
BMJ Open, 11:e054154. BMJ PUBLISHING GROUPمصطلحات موضوعية: medicine.medical_specialty, Youth, Adolescent, Joves, gastroenterology, Gastroenterology and Hepatology, Inflammatory bowel diseases, Inflammatory bowel disease, paediatric gastroenterology, VALIDATION, Young Adult, FECAL CALPROTECTIN, inflammatory bowel disease, DE-ESCALATION, Internal medicine, INFLIXIMAB, medicine, Adalimumab, Medicine and Health Sciences, Humans, Cumulative incidence, Dosing, Prospective Studies, Adverse effect, DEPRESCRIBING RPATD QUESTIONNAIRE, Randomized Controlled Trials as Topic, business.industry, Patient Preference, General Medicine, medicine.disease, Inflammatory Bowel Diseases, INDUCTION THERAPY, Faecal calprotectin, Ulcerative colitis, Infliximab, CROHNS-DISEASE, Malalties inflamatòries intestinals, ULCERATIVE-COLITIS, Medicine, Tumor Necrosis Factor Inhibitors, REVISED PATIENTS ATTITUDES, REAL-WORLD EFFECTIVENESS, business, medicine.drug
وصف الملف: application/pdf